Sept 30 (Reuters) - Heron Therapeutics Inc
* Says three members of management team will be leaving Heron Therapeutics, Inc - SEC filing
* Says resignation of Mr. Drazba will be effective as of March 31, 2017
* Accepted resignations of Neil Clendeninn, chief medical officer and Brian Drazba, chief financial officer Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.